Sanofi’s Eczema Drug Candidate Hits Main Goals in Late-Stage Trial

A

AdriΓ  Calatayud

Guest
Amlitelimab showed efficacy in skin clearance and disease severity compared to placebo in a phase 3 study with adolescent and adults with atopic dermatitis.

Continue reading...
 


Join 𝕋𝕄𝕋 on Telegram
Channel PREVIEW:
You must log in or register to reply here.
Back
Top